Judgment in the market manipulation case against Cline Scientific's CEO Patrik Sundh

Judgment has now been handed down in the case against CEO Patrik Sundh regarding market manipulation. The Stockholm district court convicted Patrik Sundh of market manipulation.

Patrik Sundh, in consultation with his legal representative, has decided to appeal the verdict. However, the company's board continues to have full confidence in the company's CEO to lead the business forward.

For more information, please contact:

Johan Bjurquist, Chairman of the Board
Phone: +46 (0)73-747 1990

Cline Scientific AB (publ)                                                
Pepparedsleden 1
AstraZeneca BioVentureHub                                               Email: info@clinescientific.com
431 53  MÖLNDAL                                                             Website: www.clinescientific.com

About Cline Scientific
Cline Scientific develops advanced cancer diagnostics and regenerative medicine treatments. Cline’s unique patented surface nanotechnology provides solutions to critical challenges for cell-based products and process in Life Science. Cline is driving two projects through to a clinical stage, StemCART - a stem cell therapy for joint repair, and CellRACE- a cancer diagnostic to predict metastasis.